ACTH stimulates insulin secretion from MIN6 cells and primary mouse and human islets of Langerhans

J Endocrinol. 2004 Jan;180(1):155-66. doi: 10.1677/joe.0.1800155.

Abstract

It has previously been suggested that ACTH and ACTH-related peptides may act as paracrine modulators of insulin secretion in the islets of Langerhans. We have, therefore, examined the expression and function of the ACTH receptor (the melanocortin 2 receptor, MC2-R) in human and mouse primary islet tIssue and in the MIN6 mouse insulinoma cell line. Mouse MC2-R mRNA was detected in both MIN6 cells and mouse islet tIssue by PCR amplification of cDNA. In perifusion experiments with MIN6 pseudo-islets, a small, transient increase in insulin secretion was obtained when ACTH(1-24) (1 nM) was added to medium containing 2 mM glucose (control) but not when the medium glucose content was increased to 8 mM. Further investigations were performed using static incubations of MIN6 cell monolayers; ACTH(1-24) (1 pM-10 nM) provoked a concentration-dependent increase in insulin secretion from MIN6 monolayer cells that achieved statistical significance at concentrations of 1 and 10 nM (150 +/- 13.6% basal secretion; 187 +/- 14.9% basal secretion, P<0.01). Similar responses were obtained with ACTH(1-39). The phosphodiesterase inhibitor IBMX (100 microM) potentiated the responses to sub-maximal doses of ACTH(1-24). Two inhibitors of the protein kinase A (PKA) signaling pathway, Rp-cAMPS (500 microM) and H-89 (10 microM), abolished the insulin secretory response to ACTH(1-24) (0.5-10 nM). Treatment with 1 nM ACTH(1-24) caused a small, statistically significant increase in intracellular cAMP levels. Secretory responses of MIN6 cells to ACTH(1-24) were also influenced by changes in extracellular Ca2+ levels. Incubation in Ca2+-free buffer supplemented with 0.1 mM EGTA blocked the MIN6 cells' secretory response to 1 and 10 nM ACTH(1-24). Similar results were obtained when a Ca2+ channel blocker (nitrendipine, 10 microM) was added to the Ca2+-containing buffer. ACTH(1-24) also evoked an insulin secretory response from primary tIssues. The addition of ACTH(1-24) (0.5 nM) to perifusions of mouse islets induced a transient increase in insulin secretion at 8 mM glucose. Perifused human primary islets also showed a secretory response to ACTH(1-24) at basal glucose concentration (2 mM) with a rapid initial spike in insulin secretion followed by a decline to basal levels. Overall the results demonstrate that the MC2-R is expressed in beta-cells and suggest that activation of the receptor by ACTH initiates insulin secretion through the activation of PKA in association with Ca2+ influx into beta-cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-Methyl-3-isobutylxanthine / pharmacology
  • Adrenocorticotropic Hormone / pharmacology*
  • Animals
  • Calcium Channel Blockers / pharmacology
  • Cell Line
  • Cells, Cultured
  • Cyclic AMP / analogs & derivatives*
  • Cyclic AMP / pharmacology
  • Cyclic AMP-Dependent Protein Kinases / antagonists & inhibitors
  • Dose-Response Relationship, Drug
  • Humans
  • Insulin / metabolism*
  • Insulin Secretion
  • Insulinoma / metabolism
  • Islets of Langerhans / drug effects
  • Islets of Langerhans / metabolism*
  • Isoquinolines / pharmacology
  • Mice
  • Nitrendipine / pharmacology
  • Paracrine Communication*
  • Phosphodiesterase Inhibitors / pharmacology
  • RNA, Messenger / analysis
  • Receptor, Melanocortin, Type 2 / genetics
  • Receptor, Melanocortin, Type 2 / metabolism
  • Stimulation, Chemical
  • Sulfonamides*
  • Thionucleotides / pharmacology

Substances

  • Calcium Channel Blockers
  • Insulin
  • Isoquinolines
  • Phosphodiesterase Inhibitors
  • RNA, Messenger
  • Receptor, Melanocortin, Type 2
  • Sulfonamides
  • Thionucleotides
  • adenosine-3',5'-cyclic phosphorothioate
  • Adrenocorticotropic Hormone
  • Nitrendipine
  • Cyclic AMP
  • Cyclic AMP-Dependent Protein Kinases
  • N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide
  • 1-Methyl-3-isobutylxanthine